|
End-of-day quote
Shenzhen S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 3.800 CNY | -0.52% |
|
-3.55% | -14.22% |
| 08-26 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Fuan Pharmaceutical Subsidiary Gets China Approval for Three Injectable Drugs | MT |
Chart: Technical Analysis
Shenzhen S.E.CNY
| Markets | Quality | ||
|---|---|---|---|
Shenzhen S.E.
| 300194 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 4.03 | 4.31 | 4.74 |
| Spread/Res. | -5.71% | -11.83% | -19.83% |
| Spread/Supp. | +1.33% | +13.77% | +13.77% |
| Support | 3.75 | 3.34 | 3.34 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 300194 Stock
- Charts Fuan Pharmaceutical (Group) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
